zoladex la depot 10,8 mg
astrazeneca ab, Švédsko - goserelín - 44 - cytostatica
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - prostatic neoplasms, kastrácia-odolný - terapeutické rádiofarmaká - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
alamycin la 200 mg/ml injekčný roztok
norbrook laboratories (ireland) ltd., Írsko - inj.
alamycin la 300 mg/ml injekčný roztok
norbrook laboratories (ireland) ltd., Írsko - inj.
betamox la 150 mg/ml injekčná suspenzia
norbrook laboratories (ireland) ltd., Írsko - inj.susp.
clamoxyl la 150 mg/ml injekčná suspenzia
zoetis Česká republika, Česká republika - inj.
cobactan la 75 mg/ml injekčná suspenzia pre ošípané
intervet international b.v., holandsko - inj.
codimox la 150 mg/ml injekčná suspenzia
kela laboratoria n.v., belgicko - inj.
duphamox la 150 mg/ml injekčná suspenzia
zoetis Česká republika, Česká republika - inj.